* Alphabetically arranged and priced on Share Price and Market Capitalisation during the time of writing on the day of Publication.
** Arranged by type of listing and date of announcement.
*** Potential means Intention to Float (ITF) or similar announcement has been made.
**** A corporate client of Hybridan LLP.
Dish of the Day
Admissions:
None
Delistings:
None
Banquet Buffet*
London Stock Exchange: Main Market and AIM
Cobra Resources 4.15p £43.55m (COBR.L)
The South Australian mineral exploration and development Company advancing the Wudinna Rare Earth Project and the Manna Hill Copper Project reported results from two of four completed Diamond Drilling holes from Blue Rose, a copper-gold-molybdenum discovery within the Manna Hill Copper Project. Extensive copper mineralisation was defined within the two holes, with MHDD002 totaling 50 metres at half a percent copper, while collective mineralisation within MHDD004 totals 80 metres at 0.30 percent copper. MHDD004 also returned a separate 16.9m intersection at 0.08% molybdenum which supports economics and provides an important vector for the system’s hydrothermal source.
Diaceutics 193.5p £163.07m (DXRX.L)
The intelligence and engagement Company unlocking the full potential of diagnostic-driven therapies today announced the expansion of its existing Diaceutics Relay (Diaceutics' PMx product) partnership with Syndax Pharmaceuticals, Inc. The Relay agreement will expand to support the commercialisation of Syndax's breakthrough acute leukaemia precision oncology medicine, helping identify eligible patients sooner and enabling more timely access to treatment opportunities. The agreement builds on the existing partnership with Syndax signed in Q4 2025 and reflects a shared commitment to improving patient outcomes through more effective patient identification and commercial execution.
European Green Transition 13.00p £33.70m (EGT.L)
The Company operating in the critical and renewable infrastructure sector has secured a five-year operations and maintenance contract renewal across a portfolio of 94 wind turbines in Great Britain and Northern Ireland with the Drax Group plc. The portfolio of 94 wind turbines was acquired by Drax as part of its acquisition of Bluefield Solar Income Fund in July 2026. Drax is a renewable and flexible generation energy company engaged in generating dispatchable power, producing sustainable biomass and selling renewable electricity to businesses. This agreement reaffirms the Board’s expectation that the Wind Services business expects to generate revenue of £17m - £18m for the twelve months ending 31 December 2026 noting revenue attributable to EGT will represent the 10-month period since Completion.
iForex Financial Trading Holdings Ltd 145.00p £32.92m (IFRX.L)
The fintech business with a proprietary online and mobile trading platform for multi-asset contracts for difference today announced its unaudited interim results for the six months ended 30 June 2026. iForex continued to advance its strategic initiatives during H1 2026 while financial performance reflects the previously announced FX headwinds and higher client liabilities at the period end as well as non-recurring IPO costs. Revenue was $26.9m, down 2.2% (H1 2025: $27.6m), reflecting resilient client activity despite lower market volatility in the core instruments. The adjusted EBITDA was $1.4m, down 74.1%, impacted by additional costs arising from the exceptional strengthening of the Israeli Shekel against the US Dollar, as well as $2.4m of IPO and non-recurring public company costs and a non-cash accounting adjustment of approximately $1.0m relating to amounts owed to clients which has largely reversed since the period end. The net cash position was $11.8m on 30 June 2026 (30 June 2025: $8.1m) with no non-lease debt.
Kazera Global 1.83p £20.10m (KZG.L)
The AIM-quoted investment Company announced that the Mining Right over Sea Concession 2A, held by the Company's South African subsidiary Whale Head Minerals (WHM), has now been formally executed by the South African Department of Mineral and Petroleum Resources. Formal execution represents the completion of the key regulatory process following the grant of the 2A Mining Right announced on 2 September and triggers a further advance payment to WHM from South Africa AT Investments Ltd under the parties' long-term Mining Cooperation and Production Sharing Agreement.
Oriole Resources 0.31p £14.69m (ORR.L)
The AIM quoted exploration and development Company focused on Central and West Africa released results for the maiden diamond drilling programme at its 85%-owned Wapouzé limestone project in north-eastern Cameroon. Marble units were encountered within every hole of the Programme with the majority of holes returning high-quality carbonate material, which included a notable intersection of 53.50m at an average of 53.88wt% CaO (calcium oxide commonly called lime) and 0.88wt% MgO (magnesium oxide) from 1.30m depth in WPDD012. Furthermore, a local-level Environmental and Social Impact Assessment is currently underway at the Project to support the submission of an Exploitation Licence Application in Q4 2026.
Poolbeg Pharma 8.70p £69.09m (POLB.L)
The clinical-stage biopharmaceutical Company with a core focus on transforming the cancer immunotherapy field announces that the ongoing TOPICAL clinical trial will proceed as planned following a positive review of data from the interim safety cohort. The completion of this review represents an important milestone for the TOPICAL trial. The review recommended that the trial continue as planned, with no changes required to the study protocol. Patient recruitment is continuing across UK clinical sites, with further patients expected to be enrolled and additional sites activated.
RC Fornax 5.20p £4.75m (RCFX.L)
The UK-based consultancy delivering outcome-based engineering solutions to the defence sector's most critical platforms has secured a second contract through the Public Sector Resourcing framework with a total value of approximately £350k. The formal purchase order has been received and will see RC Fornax provide Project Management Office support to a UK Government client for an initial period of six months. Furthermore, the Board currently expects, subject to RC Fornax performance under the contract and PSR budget allocation, that the contract will be extended for an additional six months. Should such an extension be granted, the contract would generate the Company, in aggregate, revenue of between £650k - £700k. This contract follows the Company’s recently announced £4.0m selection through the PSR Framework, which remains on track for delivery as planned.
System1 Group 350p £42.51m (SYS1.L)
The marketing decision-making platform business provided a trading update for the 5 months of FY27 which included an adjusted profit before tax of £2.1m and an increase in full year guidance (FY27) from £4.2m to £5m. As previously announced on 9 September, System1’s revenues for the first five months of FY27 were ahead of the five months ending 31 August 2025, benefiting from an increase in engagement with existing customers and continued momentum in new business performance. Effective cost management has enabled a significant year-on-year improvement in adjusted profit before tax on total revenue growth of 11%. A gross profit margin of 87% was achieved for the first five months of FY27, in line with the first five months of FY26. Total overhead expenditure in the first five months of FY27 was slightly lower than the first five months of FY26 with lower salary costs partially offset by increased marketing expenditure.
AQSE Market:
Vault Ventures 0.275p £1.0m (AQSE:VULT)
The blockchain Company today provides further details regarding its post-quantum cryptography-based technology platform which provides financial institutions and regulatory bodies with tools to support the integrity and verification of electronic communications. Through its engineering partnership with Whitespace, as announced on 9 March, the Company has continued to progress the Platform, with its core architecture now defined and a detailed use case mapped against a retail bank’s end-of-day processes. In parallel, the Company and Whitespace have established a co-designed programme, structured with specialist consulting and quantum security partners, through which regulated financial institutions are being invited to help shape the Platform’s requirements ahead of any pilot deployment. To date, three financial institutions have been invited to participate, one of which has confirmed its participation, with the partnership structure now being finalised.
What’s baking in the oven? **
Potential IPOs:***
23rd September: Chaleit Holdings a cyber security consultancy founded in 2021, announced its intention to list on the AIM Market. Chaleit plans to raise approximately £1.6m through a placing of new and existing ordinary shares and a direct subscription, with an anticipated market capitalisation of approximately £11.2m on Admission. The Cambridge-based company provides penetration testing and offensive security consultancy services, examining technology from an attacker’s perspective to identify vulnerabilities. Its services also include AI and language model security, cloud security, development security operations engineering, and cyber advisory and compliance work. The Company expects trading to commence on October 7, under the epic code CHA.
23rd September: Airtel Money, a scaled digital financial services platform operating across 13 African markets, has announced its intention to undertake an IPO on to the Main Market of the London Stock Exchange. As of 30 June, Airtel served approximately 53m monthly active users with a suite of mobile financial services such as micro-loans, savings accounts, insurance, wealth products. It was founded in 2011. Its growth to date has been helped by its relationship with Airtel Africa plc, its founding shareholder. Revenue reached US$1.346bn for the year ended 31 March 2026, with an EBITDA margin of approximately 50%. The Group has no external borrowings and capital expenditure represented just 3% of revenue in the year ended 31 March 2026. The IPO Offer consists solely of shares sold by existing shareholders; no new capital is being raised. The Offer will be made to qualified institutional buyers in the US and to certain institutional investors outside of the US. The Offer will also be made to retail investors in the UK through Retail Book Limited. In connection with the Offer, each of the Company, its directors and its existing shareholders are expected to agree to customary lock-up arrangements. The Prospectus is expected to be published in early October 2026 and the IPO complete mid-October 2026 with a free float of at least 10%.
5th August: 1947 Oil & Gas, the newly incorporated oil and gas production Company focused on acquiring, operating and growing a portfolio of producing assets in the US, announced its intention to IPO onto AIM. In connection with Admission, the Company has entered into a conditional agreement to acquire Renaissance Offshore, LLC, a privately held, Houston-based oil and gas production Company with interests in eleven fields located in the shallow-water Gulf of America. The Company is raising an updated amount of £40m and the expected market capitalisation of the Company on Admission will be £70m. Admission is expected to now occur in late-September.
Dual Listings:***
18th August: Aimia Inc. (TSX: AIM; JSE: AII) the Canadian diversified conglomerate announced plans to dual list on AIM. It owns a selection of businesses which include: (i) an 100% interest in Cortland International Inc., a global designer, manufacturer and supplier of synthetic fiber ropes, nets, slings and tethers; a (ii) 10.85% indirect stake in Clear Media Limited, the largest operator of bus shelter advertising panels in China; and (iii) the Company holds a portfolio of publicly listed securities amounting C$12m as of 30 June 2026. No capital is expected to be raised on Admission and deal details remain TBC. Expected first day of dealings updated date of 29 September.
Status of this Note and Disclaimer
This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. The information has been provided without taking into account the investment objective, financial situation or needs of any particular person. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
As market commentary, this document is not investment research or a research recommendation for regulatory purposes as it does not constitute substantive research or analysis. It is not subject to any prohibition on dealing ahead of the dissemination of investment research although Hybridan LLP maintains related internal systems and controls in connection with such dealing.
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result, both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
This document is not intended to be an invitation or inducement to engage in investment activity. In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are categorised by Hybridan LLP as either a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the avoidance of doubt, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. The information may contain projections or other forward-looking statements regarding future events, targets or expectations. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein.
References to specific securities, asset classes and financial markets are for illustrative purposes only. Past performance is no guarantee of future results. Information and opinions presented have been obtained or derived from sources which Hybridan LLP reasonably believed to be reliable however no representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any losses arising in any way from use of all or any part of the information in this document including, for the avoidance of doubt, direct or indirect or consequential loss or damage (including lost profits).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication.
In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Unless otherwise stated, Hybridan LLP owns the intellectual property rights and any other rights in this document. This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
